This inventor holds 5 USPTO granted patents. Top assignees: Genentech, Inc., Hoechst Aktiengesellschaft, Other. Active years: 1999-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,299 
1 out of 6,705 
4 out of 834,513 Years Active: 1999-2004
Title: Karlheinz Scheunemann: Innovator in Pharmaceutical Chemistry
Introduction
Karlheinz Scheunemann is a notable inventor based in Liederbach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit bone resorption and cell adhesion.
Latest Patents
Scheunemann holds 5 patents, with his latest innovations focusing on sulfonamide derivatives. These derivatives serve as inhibitors of bone resorption and cell adhesion, acting as vitronectin receptor antagonists. The compounds are designed to be pharmaceutically active, providing therapeutic benefits for conditions such as osteoporosis. His patents also detail processes for preparing these sulfonamide derivatives and their applications in pharmaceutical formulations.
Career Highlights
Throughout his career, Scheunemann has worked with prominent companies, including Hoechst Aktiengesellschaft. His work has been instrumental in advancing the understanding and treatment of diseases related to bone resorption.
Collaborations
He has collaborated with notable colleagues, including Anuschirwan Peyman and Denis Carniato, contributing to the advancement of pharmaceutical research.
Conclusion
Karlheinz Scheunemann's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of bone-related diseases. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile